Endometrial cancer: predictors of response and preferred endocrine therapy
Int J Gynecol Cancer
.
2006:16 Suppl 2:527-8.
doi: 10.1111/j.1525-1438.2006.00688.x.
Authors
F Amant
1
,
K Leunen
,
P Neven
,
P Berteloot
,
I Vergote
Affiliation
1
Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, UZ Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.
PMID:
17010065
DOI:
10.1111/j.1525-1438.2006.00688.x
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents, Hormonal / therapeutic use*
Endometrial Neoplasms / drug therapy*
Female
Humans
Substances
Antineoplastic Agents, Hormonal